C reactive protein and procalcitonin levels for the diagnosis of invasive bacterial infections in allogenic hematopoietic stem cell transplantation recipients;Proteína C reactiva y procalcitonina como marcadores de infección bacteriana en niños con neutropenia febril posterior a trasplante alogénico de progenitores hematopoyéticos

Revista Medica de Chile

Volumn 135, Issue 8, 2007, Pages 982-989

  Schmidt, Nadia ^a,c   Palma, Julia ^a,b   King, Alejandra ^a,b   Santolaya, María Elena ^a,b  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL LUIS CALVO MACKENNA   (Chile)

^c NONE   (Chile)

Author keywords

Bacterial infections; C reactive protein; Hematopoietic stem cells

Indexed keywords

EID: 36248968034     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. MULLEN C, NAIR J, SANDESH S, CHAN K. Fever and neutropenia in pediatric hematopoietic stem cell transplant patients. Bone Marrow Trasplantation 2000; 25: 59-65.
2. PALMA J, MOSSO C, PARIS C, CAMPBELL M, TONG X, KING A. Establishment of a pediatric HSCT program in a public hospital in Chile. Pediatr Blood Cancer 2006; 46: 803-10.
3. ROMANO V, CASTAGNOLA E, DALLORSO S, LANINO E, CALVI A, SILVESTRO S ET AL. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogenic bone marrow transplantation. Bone Marrow Trasplantation 1999; 23: 271-5.
4. JAYE D, KEN B. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J 1997; 16: 735-47.
5. SANTOLAYA M, COFRÉ J, BERESI V. C-reactive protein: A valuable aid for the management of febrile children with cancer and neutropenia. Clinical Infectious Dis 1994; 18: 589-95.
6. SANTOLAYA M, ALVAREZ A, BECKER A, COFRÉ J, ENRÍQUEZ N, O'RYAN M ET AL. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia and fever. Journal of Clinical Oncology 2001; 14: 3415-21.
7. CASADO J, BLANCO A. Procalcitonina: un nuevo marcador de infección bacteriana. Anales españoles de pediatría 2001; 54: 69-73.
8. GENDREL D, BOHUON C. Procalcitonin as a marker of bacterial infections. Pediatr Infect Dis J 2000; 19: 679-88.
9. CHIESA C, PANERO A, ROSSI N, STEGAGNO M, DE GIUSTI M, OSBORN J ET AL. Reability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clinical Infections Diseases 1998; 26: 664-72.
10. FLEISCHHACK G, KAMBECK I, CIPIC D, HASAN C, BODE U. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. British Journal of Haematology 2000; 111: 1093-102.
11. SAUER M, TIEDE K, FUCHS D, GRUHN B, BERGER D, ZINTL F. Procalcitonin, C-Reactive Protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbidity and mortality from sepsis. Bone Marrow Transplantation 2003; 31: 1137-42.
12. GENDREL D, RAYMOND J, COSTE J, MOULIN F, LORROT M, GUERIN S ET AL. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs viral infections. Pediatr Infect Dis J 1999; 18: 875-81.
13. CLAEYS R, VINKEN S, SPAPEN H, ELST K, DECOCHEZ K, HUYGHENS L ET AL. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002; 30: 757-62.
14. FRANZ A, KRON M, POHLANDT F, STEINBACH G. Comparison of procalcitonin with interleukin 8, C-reactive protein and differential white blood cell count for the early diagnosis of bacterial infections in newborn infants. Pediatr Infect Dis J 1999; 18: 666-71.
15. CASADO J, BLANCO A, ASENSIO J, ARRANZ E, GARROTE J, NIETO M. Serum procalcitonin in children with suspected sepsis: A comparison with C-Reactive protein and neutrophil count. Pediatr Crit Care Med 2003; 4: 190-5.
16. SANTOLAYA ME, ALVAREZ AM, AVILES CL, BECKER A, O'RYAN M, PAYA E ET AL. Prospective Evaluation of a Model of Prediction of Invasive Bacterial Infection Risk among Children with Cancer, Fever and Neutropenia. Clin Infect Dis 2002; 35: 678-83.
17. SANTOLAYA M, ALVAREZ AM, AVILES CL, BECKER A, O'RYAN M, PAYA E ET AL. Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode. Ped Infect Dis J 2007. En prensa.
18. HAMBACH L, EDER M, DAMMANN E, SCHRAUDER A, SYKORA K, DIETERICH C ET AL. Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogenic stem cell transplantation. Haematologica 2002; 87: 643-51.
19. SCHOTS R, VAN RIET I, BEN OTHMAN T, TRULLEMANS F, DE WAELE M, VAN CAMP B ET AL. Early increase in serum levels of C-reactive protein is an independent risk factor for the occurrence of major complications and 100-day transplant-related mortality after allogenic bone marrow transplantation. Bone Marrow Transplantation 2002; 30: 441-6.
20. TAKATSUKA H, TAKEMOTO Y, YAMADA S, WADA H, TAMURA S, FUJIMORI Y ET AL. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant 2000; 26: 419-26.
21. HAN Y, DOUGHTY L, KOFOS D, SASSER H, CARCILLO J. Procalcitonin is persistently increased among children with poor outcome from bacterial sepsis. Pediatr Crit Care Med 2003; 4: 21-25.